| 前收盘价格 | 32.33 |
| 收盘价格 | 31.76 |
| 成交量 | 335,724 |
| 平均成交量 (3个月) | 599,161 |
| 市值 | 1,565,345,024 |
| 价格/销量 (P/S) | 3.43 |
| 股市价格/股市净资产 (P/B) | 3.80 |
| 52周波幅 | |
| 利润日期 | 28 Jul 2025 - 1 Aug 2025 |
| 营业毛利率 | -7.95% |
| 营业利益率 (TTM) | -4.82% |
| 稀释每股收益 (EPS TTM) | -0.810 |
| 季度收入增长率 (YOY) | 13.60% |
| 总债务/股东权益 (D/E MRQ) | 17.03% |
| 流动比率 (MRQ) | 4.11 |
| 营业现金流 (OCF TTM) | 22.19 M |
| 杠杆自由现金流 (LFCF TTM) | -10.42 M |
| 资产报酬率 (ROA TTM) | -3.70% |
| 股东权益报酬率 (ROE TTM) | -8.38% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 看跌 | 混合的 |
| Medical Instruments & Supplies (全球的) | 看跌 | 看跌 | |
| 股票 | AtriCure, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -5.0 |
| 技术振荡指标 | -3.5 |
| 平均 | -1.38 |
|
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Growth |
| 内部持股比例 | 3.36% |
| 机构持股比例 | 103.60% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 60.00 (JMP Securities, 89.75%) | 购买 |
| 60.00 (Citizens Capital Markets, 89.75%) | 购买 | |
| 中 | 55.00 (73.94%) | |
| 低 | 44.00 (Needham, 39.15%) | 购买 |
| 平均值 | 53.33 (68.66%) | |
| 总计 | 6 购买 | |
| 平均价格@调整类型 | 31.68 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| JMP Securities | 30 Apr 2025 | 60.00 (89.75%) | 购买 | 29.91 |
| Needham | 30 Apr 2025 | 44.00 (39.15%) | 购买 | 29.91 |
| 27 Mar 2025 | 51.00 (61.29%) | 购买 | 34.37 | |
| UBS | 30 Apr 2025 | 58.00 (83.43%) | 购买 | 29.91 |
| Citizens Capital Markets | 02 Apr 2025 | 60.00 (89.75%) | 购买 | 34.13 |
| Canaccord Genuity | 28 Mar 2025 | 52.00 (64.45%) | 购买 | 31.83 |
| JP Morgan | 27 Mar 2025 | 46.00 (45.48%) | 购买 | 34.37 |
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 23 May 2025 | 公告 | AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference |
| 29 Apr 2025 | 公告 | AtriCure Reports First Quarter 2025 Financial Results |
| 10 Apr 2025 | 公告 | AtriCure Announces First Use of the AtriClip PRO-Mini® Device |
| 08 Apr 2025 | 公告 | AtriCure to Announce First Quarter 2025 Financial Results |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合